Craven P A, Neidig M, DeRubertis F R
Cancer Res. 1985 Mar;45(3):1115-21.
The present study examined fatty acid-initiated metabolism of methylazoxymethanol (MAM) to formaldehyde (HCHO) by the 10,000 X g soluble fraction of rat colonic mucosa, and the role of prostaglandin synthase and lipoxygenase activities in mediating this process. Incubation of MAM with soluble fractions of rat colonic mucosa, in the absence of arachidonate, resulted in significant HCHO production compared to that observed in buffer alone or with the heated tissue fractions. Addition of arachidonate (100 microM), linoleate (100 microM), or arachidonate hydroperoxide, but not palmitate, increased HCHO formation by 50%. Indomethacin (25 to 100 microM) suppressed basal and arachidonate-stimulated HCHO production by 25 to 50%. However, indomethacin did not influence linoleate or arachidonate hydroperoxide-induced increases in HCHO. These data suggested a peroxidative mechanism for MAM oxidation, that was mediated in part by arachidonate metabolism via the prostaglandin synthase system. 5,8,11,14-Eicosatetraynoic acid (25 to 500 microM) suppressed HCHO production by 30 to 80% in the absence of fatty acids, and abolished stimulation by arachidonate or linoleate, but not by arachidonate hydroperoxide. MAM was also oxidized by an NAD+-dependent dehydrogenase, as evidenced by MAM-mediated NAD reduction in 10,000 X g soluble fractions of rat colonic mucosa. On a molar basis, the ability of the soluble fraction of rat colonic mucosa to oxidize MAM by the NAD+-dependent dehydrogenase pathway and the fatty acid-stimulated pathway were similar. However, NADPH did not stimulate HCHO formation by MAM. Moreover, 7,8-naphthoflavone; 2-diethylaminoethyl-2,2-diphenylvalerate; and methimazole, inhibitors of mixed-function oxidase activity, did not suppress HCHO formation, implying that MAM was not metabolized by the colonic mixed-function oxidase activity. MAM metabolism to HCHO was 3 to 4 times greater by soluble fractions of superficial epithelial cells isolated from rat colon compared to those of the isolated proliferative epithelial cell pool. The results are consistent with a role for both the prostaglandin synthase and lipoxygenase systems of colonic mucosa in the oxidative metabolism of MAM. Enhanced oxidation of MAM by superficial cells of colonic epithelium which are preparing to slough may serve to protect the colon against the carcinogenic effect of this drug.
本研究检测了大鼠结肠黏膜10000×g可溶部分将甲基偶氮甲醇(MAM)通过脂肪酸启动代谢为甲醛(HCHO)的过程,以及前列腺素合酶和脂氧合酶活性在介导此过程中的作用。在不存在花生四烯酸的情况下,将MAM与大鼠结肠黏膜可溶部分一起孵育,与单独在缓冲液中或与加热的组织部分孵育相比,可产生大量的HCHO。添加花生四烯酸(100μM)、亚油酸(100μM)或花生四烯酸氢过氧化物(而非棕榈酸)可使HCHO生成增加50%。吲哚美辛(25至100μM)可使基础的和花生四烯酸刺激的HCHO生成量减少25%至50%。然而,吲哚美辛并不影响亚油酸或花生四烯酸氢过氧化物诱导的HCHO生成增加。这些数据提示MAM氧化存在一种过氧化机制,该机制部分由通过前列腺素合酶系统的花生四烯酸代谢介导。在不存在脂肪酸的情况下,5,8,11,14 - 二十碳四烯酸(25至500μM)可使HCHO生成量减少30%至80%,并消除花生四烯酸或亚油酸的刺激作用,但对花生四烯酸氢过氧化物的刺激作用无影响。MAM也可被一种依赖NAD + 的脱氢酶氧化,这可通过大鼠结肠黏膜10000×g可溶部分中MAM介导的NAD还原得以证明。以摩尔为基础,大鼠结肠黏膜可溶部分通过依赖NAD + 的脱氢酶途径和脂肪酸刺激途径氧化MAM的能力相似。然而,NADPH并不刺激MAM生成HCHO。此外,7,8 - 萘黄酮、2 - 二乙氨基乙基 - 2,2 - 二苯基戊酸酯和甲巯咪唑(混合功能氧化酶活性抑制剂)均不抑制HCHO生成,这意味着MAM并非通过结肠混合功能氧化酶活性进行代谢。与分离的增殖上皮细胞池相比,从大鼠结肠分离的表层上皮细胞可溶部分将MAM代谢为HCHO的能力高3至4倍。这些结果与结肠黏膜的前列腺素合酶和脂氧合酶系统在MAM氧化代谢中的作用一致。准备脱落的结肠上皮表层细胞对MAM氧化的增强可能有助于保护结肠免受该药物的致癌作用。